After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

A top-of-mind question for many clinical trial workers is whether AI could lead to job loss. After all, Goldman Sachs recently estimated that 300 million jobs could be lost or degraded due to AI ...

Accelerating medicine’s AI race, Google is releasing a version of its generative language model Med-Palm 2 to health care customers. ... or match patients to certain treatments or clinical trials.

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

The tool, called Vertex AI Search for healthcare, is also newly backed by Google’s latest AI model, Google announced Monday. The model, called Gemini 2.0, is faster and more accurate than past ...

Google has unveiled a groundbreaking AI model called Med-Gemini, specifically designed to assist doctors and healthcare staff. This innovative medical AI tool aims to significantly enhance the ...

Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report. Jan. 21, 2025 9:39 AM ET Alphabet Inc. (GOOG) Stock, GOOGL Stock By: Ravikash Bakolia, SA News Editor 2 Comments.